GLYBURIDE AND METFORMIN HYDROCHLORIDE (glyburide-metformin hydrochloride) by Charter Medical is pancreas, an effect dependent upon functioning beta cells in the pancreatic islets. Approved for type 2 diabetes mellitus. First approved in 2009.
Drug data last refreshed 23h ago
pancreas, an effect dependent upon functioning beta cells in the pancreatic islets. Sulfonylureas bind to the sulfonylurea receptor in the pancreatic beta-cell plasma membrane, leading to closure of the ATP-sensitive potassium channel, thereby stimulating the release of insulin. Metformin is an…
Sulfonylurea
Worked on GLYBURIDE AND METFORMIN HYDROCHLORIDE at Charter Medical? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.